Roche Backs Out Of Kosan Epothilone Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Kosan is “actively seeking” a new partner to begin Phase II trial for KOS-1584 after Roche unexpectedly terminates five-year collaboration.